CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.8

ph-index = 11

Forward Citations = 596(Granted Patents)

Location History:

Princeton, NJ (US) (1980 - 2011)
Minneapolis, MN (US) (2010 - 2013)

Company Filing History:

16 out of 1,624

E. R. Squibb Sons, Inc.

patents

14 out of 3,681

Bristol-myers Squibb Compnay

where one patent can have more than one assignee

Years Active: 1980-2013

Loading Chart...

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8614332 - Substituted pyrazolylamides useful as glucokinase activators (2013-12-24),

2. 8273777 - Glucokinase activators and methods of using same (2012-09-25),

3. 8263659 - Thyroid receptor ligands (2012-09-11),

4. 8153677 - Substituted pyrazolylamide compounds useful as glucokinase activators (2012-04-10),

5. 7910747 - Phosphonate and phosphinate pyrazolylamide glucokinase activators (2011-03-22),

6. 7812048 - Glucokinase activators and methods of using same (2010-10-12),

7. 7557143 - Thyroid receptor ligands (2009-07-07),

8. 7342127 - Substituted anilide ligands for the thyroid receptor (2008-03-11),

9. 7288571 - Thyroid receptor ligands and method II (2007-10-30),

10. 7153997 - Benzamide derivatives as thyroid receptor ligands (2006-12-26),

11. 7109164 - Aniline-derived ligands for the thyroid receptor (2006-09-19),

12. 6989402 - Thyroid receptor ligands and method II (2006-01-24),

13. 6800605 - Aniline-derived ligands for the thyroid receptor (2004-10-05),

14. 6395784 - Benzamide ligands for the thyroid receptor (2002-05-28),

15. 6117885 - Biphenyl-substituted quinoline derivatives (2000-09-12),

Title: Innovations by Denis E. Ryono: A Pioneer in Diabetes Treatment

Introduction: Denis E. Ryono, based in Princeton, NJ, is a distinguished inventor with an impressive portfolio of 32 patents. His work primarily focuses on novel compounds aimed at treating diabetes and related diseases, demonstrating his commitment to advancing medical science through innovation.

Latest Patents: Among his latest patents, Ryono has developed "Substituted pyrazolylamides useful as glucokinase activators." These compounds serve as phosphonate and phosphinate activators, proving beneficial in the treatment of diabetes and related disorders. Another significant patent is for "Glucokinase activators and methods of using same," where he details compounds that activate the enzyme glucokinase, key to managing diabetes. Both patents include methods for employing these innovative compounds in therapeutic applications.

Career Highlights: Throughout his career, Denis E. Ryono has worked for notable companies such as E.R. Squibb & Sons, Inc. and Bristol-Myers Squibb Company. His contributions have significantly impacted the pharmaceutical industry, leading to advancements in diabetes treatment.

Collaborations: Ryono has collaborated with esteemed professionals in the field, including Edward W. Petrillo, Jr. and Minsheng Zhang. These partnerships have facilitated the development of groundbreaking innovations that address critical health challenges.

Conclusion: Denis E. Ryono's significant contributions to medical research and his extensive patent portfolio underscore his role as a leader in innovation. His work continues to pave the way for new treatments in diabetes care, reinforcing the importance of collaboration among inventors and researchers in driving progress in healthcare.

This text is generated by artificial intelligence and may not be accurate.